Protagonist Therapeutics, Inc. (PTGX) vs TG Therapeutics, Inc. (TGTX)
- Protagonist Therapeutics, Inc. PTGX 128.75 −5.71%
- TG Therapeutics, Inc. TGTX 53.97 −3.63%
Protagonist Therapeutics, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. Protagonist Therapeutics, Inc. and TG Therapeutics, Inc. are of similar size ($8.8B and $8.6B). TG Therapeutics, Inc. trades at the lower P/E: 17.8× against 106×. TG Therapeutics, Inc. grew revenue faster over the last twelve months: 76.1% against 34.8%. TG Therapeutics, Inc. has the higher net margin (55.2% vs 29.4%) and the lower return on invested capital (10.7% vs 61.8%). Across the 21 metrics below, TG Therapeutics, Inc. leads on 12 and Protagonist Therapeutics, Inc. on 9.
Valuation
Profitability
| Metric | PTGX | TGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.37% | 65.16% |
| Operating margin | 20.69% | 17.05% | 0.00% |
| Net margin | 29.40% | 55.22% | 0.00% |
| Free cash flow margin | 46.31% | 2.17% | 0.00% |
| Return on equity | 10.98% | 100.28% | (56.36%) |
| Return on assets | 10.34% | 37.70% | (48.04%) |
| Return on invested capital | 61.84% | 10.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack